Immune containment and consequences of measles virus infection in healthy and immunocompromised individuals

Clinical and Vaccine Immunology

Volumn 13, Issue 4, 2006, Pages 437-443

  Permar, Sallie R ^a   Griffin, Diane E ^b   Letvin, Norman L ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD150 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MEASLES ANTIBODY; MEMBRANE COFACTOR PROTEIN; NEUTRALIZING ANTIBODY;

B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOCOMPETENCE; LYMPHOCYTE PROLIFERATION; LYMPHOCYTOPENIA; MEASLES; MEASLES VIRUS; MEMORY T LYMPHOCYTE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SHORT SURVEY; TH1 CELL; TH2 CELL; VIREMIA; VIRUS IMMUNITY;

ANIMALS; HUMANS; IMMUNOCOMPROMISED HOST; MEASLES; MEASLES VIRUS;

EID: 33745910244     PISSN: 15566811     EISSN: None     Source Type: Journal    
DOI: 10.1128/CVI.13.4.437-443.2006     Document Type: Short Survey

References (140)

1. Addae, M. M., Y. Komada, X. L. Zhang, and M. Sakurai. 1995. Immunological unresponsiveness and apoptotic cell death of T cells in measles virus infection. Acta Paediatr. Jpn. 37:308-314.
2. Albrecht, P., D. Lorenz, M. J. Klutch, J. H. Vickers, and F. A. Ennis. 1980. Fatal measles infection in marmoset pathogenesis and prophylaxis. Infect. Immun. 27:969-978.
3. American Academy of Pediatrics. 1999. Measles immunization in HIV-infected children. American Academy of Pediatrics. Committee on Infectious Diseases and Committee on Pediatric AIDS. Pediatrics 103:1057-1060.
4. Arneborn, P., and G. Biberfeld. 1983. T-lymphocyte subpopulations in relation to immunosuppression in measles and varicella. Infect. Immun. 39:29-37.
5. Auwaerter, P. G., H. Kaneshima, J. M. McCune, G. Wiegand, and D. E. Griffin. 1996. Measles virus infection of thymic epithelium in the SCID-hu mouse leads to thymocyte apoptosis. J. Virol. 70:3734-3740.
6. Auwaerter, P. G., P. A. Rota, W. R. Elkins, R. J. Adams, T. DeLozier, Y. Shi, W. J. Bellini, B. R. Murphy, and D. E. Griffin. 1999. Measles virus infection in rhesus macaques: altered immune responses and comparison of the virulence of six different virus strains. J. Infect. Dis. 180:950-958.
7. Avota, E., A. Avots, S. Niewiesk, L. P. Kane, U. Bommhardt, V. ter Meulen, and S. Schneider-Schaulies. 2001. Disruption of Akt kinase activation is important for immunosuppression induced by measles virus. Nat. Med. 7:725-731.
8. Avota, E., N. Muller, M. Klett, and S. Schneider-Schaulies. 2004. Measles virus interacts with and alters signal transduction in T-cell lipid rafts. J. Virol. 78:9552-9559.
9. Barry, D. W., J. L. Sullivan, S. J. Lucas, R. C. Dunlap, and P. Albrecht. 1976. Acute and chronic infection of human lymphoblastoid cell lines with measles virus. J. Immunol. 116:89-98.
10. Beckford, A. P., R. O. Kaschula, and C. Stephen. 1985. Factors associated with fatal cases of measles. A retrospective autopsy study. S. Afr. Med. J. 68:858-863.
11. Bell, A., A. King, K. Pielak, and M. Fyfe. 1997. Epidemiology of measles outbreak in British Columbia-February 1997. Can. Commun. Dis. Rep. 23:49-51.
12. Bell, A. F., J. B. Burns, and R. S. Fujinami. 1997. Measles virus infection of human T cells modulates cytokine generation and IL-2 receptor alpha chain expression. Virology 232:241-247.
13. Bellini, W. J., D. E. McFarlin, G. D. Silver, E. S. Mingioli, and H. F. McFarland. 1981. Immune reactivity of the purified hemagglutinin of measles virus. Infect. Immun. 32:1051-1057.
14. Black, F. L., and L. Rosen. 1962. Patterns of measles antibodies in residents of Tahiti and their stability in the absence of re-exposure. J. Immunol. 88:725-731.
15. Blixenkrone-Moller, M., A. Bernard, A. Bencsik, N. Sixt, L. E. Diamond, J. S. Logan, and T. F. Wild. 1998. Role of CD46 in measles virus infection in CD46 transgenic mice. Virology 249:238-248.
16. Budka, H., H. Lassmann, and T. Popow-Kraupp. 1982. Measles virus antigen in panencephalitis. An immunomorphological study stressing dendritic involvement in SSPE. Acta Neuropathol. 56:52-62.
17. Casali, P., G. P. Rice, and M. B. Oldstone. 1984. Viruses disrupt functions of human lymphocytes. Effects of measles virus and influenza virus on lymphocyte-mediated killing and antibody production. J. Exp. Med. 159:1322-1337.
18. Centers for Disease Control and Prevention. 1988. Measles in HIV-infected children, United States. Morb. Mortal. Wkly. Rep. 37:183-186.
19. Centers for Disease Control and Prevention. 1996. Measles pneumonitis following measles-mumps-rubella vaccination of a patient with HIV infection, 1993. Morb. Mortal. Wkly. Rep. 45:603-606.
20. Chandwani, S., M. A. Greco, K. Mittal, C. Antoine, K. Krasinski, and W. Borkowsky. 1991. Pathology and human immunodeficiency virus expression in placentas of seropositive women. J. Infect. Dis. 163:1134-1138.
21. Chen, R. T., L. E. Markowitz, P. Albrecht, J. A. Stewart, L. M. Mofenson, S. R. Preblud, and W. A. Orenstein. 1990. Measles antibody: reevaluation of protective titers. J. Infect. Dis. 162:1036-1042.
22. Choi, Y. K., M. A. Simon, D. Y. Kim, B. I. Yoon, S. W. Kwon, K. W. Lee, and I. B. Seo. 1999. Fatal measles virus infection in Japanese macaques (Macaca fuscata). Vet. Pathol. 36:594-600.
23. Christensen, P., et al. 1951. An epidemic of measles in Southern Greenland. Acta Med. Scand. 144:431.
24. Connecticut State Medical Society. 1988. Measles in HIV-infected children, United States. Conn. Med. 52:292-293.
25. Dubois, B., P. J. Lamy, K. Chemin, A. Lachaux, and D. Kaiserlian. 2001. Measles virus exploits dendritic cells to suppress CD44+ T-cell proliferation via expression of surface viral glycoproteins independently of T-cell transinfection. Cell. Immunol. 214:173-183.
26. Duggan, M. B., J. Alwar, and R. D. Milner. 1986. The nutritional cost of measles in Africa. Arch. Dis. Child. 61:61-66.
27. Enders, J. F., S. L. Katz, M. V. Milovanovic, and A. Holloway. 1960. Studies of an attenuated measles virus vaccine. I. Development and preparation of the vaccine: techniques for assay of effects of vaccination. N. Engl. J. Med. 263:153-159.
28. Enders, J. F., K. McCarthy, A. Mitus, and W. J. Cheatham. 1959. Isolation of measles virus at autopsy in cases of giant cell pneumonia without rash. N. Engl. J. Med. 261:875-881.
29. Esolen, L. M., B. J. Ward, T. R. Moench, and D. E. Griffin. 1993. Infection of monocytes during measles. J. Infect. Dis. 168:47-52.
30. Forni, A. L., N. W. Schluger, and R. B. Roberts. 1994. Severe measles pneumonitis in adults: evaluation of clinical characteristics and therapy with intravenous ribavirin. Clin. Infect. Dis. 19:454-462.
31. Forthal, D. N., G. Landucci, A. Habis, M. Zartarian, J. Katz, and J. G. Tilles. 1994. Measles virus-specific functional antibody responses and viremia during acute measles. J. Infect. Dis. 169:1377-1380.
32. Friedman, S. 1991. Measles in New York City. JAMA 266:1220.
33. Fugier-Vivier, I., C. Servet-Delprat, P. Rivailler, M. C. Rissoan, Y. J. Liu, and C. Rabourdin-Combe. 1997. Measles virus suppresses cell-mediated immunity by interfering with the survival and functions of dendritic and T cells. J. Exp. Med. 186:813-823.
34. Fujinami, R. S., and M. B. Oldstone. 1980. Alterations in expression of measles virus polypeptides by antibody: molecular events in antibody-induced antigenic modulation. J. Immunol. 125:78-85.
35. Fujinami, R. S., and M. B. Oldstone. 1979. Antiviral antibody reacting on the plasma membrane alters measles virus expression inside the cell. Nature 279:529-530.
36. Fujinami, R. S., X. Sun, J. M. Howell, J. C. Jenkin, and J. B. Burns. 1998. Modulation of immune system function by measles virus infection: role of soluble factor and direct infection. J. Virol. 72:9421-9427.
37. Good, R. A., and S. J. Zak. 1956. Disturbances in gammaglobulinemia synthesis as "experiments of nature." Pediatrics 18:109-149.
38. Griffin, D. E., R. T. Johnson, V. G. Tamashiro, T. R. Moench, E. Jauregui, I. Lindo de Soriano, and A. Vaisberg. 1987. In vitro studies of the role of monocytes in the immunosuppression associated with natural measles virus infections. Clin. Immunol. Immunopathol. 45:375-383.
39. Griffin, D. E., T. R. Moench, R. T. Johnson, I. Lindo de Soriano, and A. Vaisberg. 1986. Peripheral blood mononuclear cells during natural measles virus infection: cell surface phenotypes and evidence for activation. Clin. Immunol. Immunopathol. 40:305-312.
40. Griffin, D. E., and B. J. Ward. 1993. Differential CD4 T cell activation in measles. J. Infect. Dis. 168:275-281.
41. Griffin, D. E., B. J. Ward, E. Jauregui, R. T. Johnson, and A. Vaisberg. 1990. Immune activation during measles: interferon-gamma and neopterin in plasma and cerebrospinal fluid in complicated and uncomplicated disease. J. Infect. Dis. 161:449-453.
42. Griffin, D. E., B. J. Ward, E. Jauregui, R. T. Johnson, and A. Vaisberg. 1989. Immune activation in measles. N. Engl. J. Med. 320:1667-1672.
43. Griffin, D. E., B. J. Ward, E. Juaregui, R. T. Johnson, and A. Vaisberg. 1992. Immune activation during measles: beta 2-microglobulin in plasma and cerebrospinal fluid in complicated and uncomplicated disease. J. Infect. Dis. 166:1170-1173.
44. Grosjean, I., C. Caux, C. Bella, I. Berger, F. Wild, J. Banchereau, and D. Kaiserlian. 1997. Measles virus infects human dendritic cells and blocks their allostimulatory properties for CD4+ T cells. J. Exp. Med. 186:801-812.
45. Hickman, C. J., A. S. Khan, P. A. Rota, and W. J. Bellini. 1997. Use of synthetic peptides to identify measles nucleoprotein T-cell epitopes in vaccinated and naturally infected humans. Virology 235:386-397.
46. Hicks, J. T., J. L. Sullivan, and P. Albrecht. 1977. Immune responses during measles infection in immunosuppressed rhesus monkeys. J. Immunol. 119:1452-1456.
47. Horvat, B., P. Rivailler, G. Varior-Krishnan, A. Cardoso, D. Gerlier, and C. Rarourdin-Combe. 1996. Transgenic mice expressing human measles virus (MV) receptor CD46 provide cells exhibiting different permissivities to MV infections. J. Virol. 70:6673-6681.
48. Huddlestone, J. R., P. W. Lampert, and M. B. Oldstone. 1980. Virus-lymphocyte interactions: infection of Tg and Tm subsets by measles virus. Clin. Immunol. Immunopathol. 15:502-509.
49. Hyypia, T., P. Korkiamaki, and R. Vainionpaa. 1985. Replication of measles virus in human lymphocytes. J. Exp. Med. 161:1261-1271.
50. Ilonen, J., M. J. Makela, B. Ziola, and A. A. Salmi. 1990. Cloning of human T cells specific for measles virus haemagglutinin and nucleocapsid. Clin. Exp. Immunol. 81:212-217.
51. Ilonen, J., R. Salonen, R. Marusyk, and A. Salmi. 1988. Measles virus strain-dependent variation in outcome of infection of human blood mononuclear cells. J. Gen. Virol. 69:247-252.
52. Imani, F., D. Proud, and D. E. Griffin. 1999. Measles virus infection synergizes with IL-4 in IgE class switching. J. Immunol. 162:1597-1602.
53. Jaye, A., A. F. Magnusen, A. D. Sadiq, T. Corrah, and H. C. Whittle. 1998. Ex vivo analysis of cytotoxic T lymphocytes to measles antigens during infection and after vaccination in Gambian children. J. Clin. Investig. 102:1969-1977.
54. Jaye, A., A. F. Magnusen, and H. C. Whittle. 1998. Human leukocyte antigen class I- and class II-restricted cytotoxic T lymphocyte responses to measles antigens in immune adults. J. Infect. Dis. 177:1282-1289.
55. Joseph, B. S., and M. B. Oldstone. 1975. Immunologic injury in measles virus infection. II. Suppression of immune injury through antigenic modulation. J. Exp. Med. 142:864-876.
56. Kaplan, L. J., R. S. Daum, M. Smaron, and C. A. McCarthy. 1992. Severe measles in immunocompromised patients. JAMA 267:1237-1241.
57. Karp, C. L. 1999. Measles: immunosuppression, interleukin-12, and complement receptors. Immunol. Rev. 168:91-101.
58. King, N. W., R. D. Hunt, and N. L. Letvin. 1983. Histopathologic changes in macaques with an acquired immunodeficiency syndrome (AIDS). Am. J. Pathol. 113:382-388.
59. Klagge, I. M., M. Abt, B. Fries, and S. Schneider-Schaulies. 2004. Impact of measles virus dendritic-cell infection on Th-cell polarization in vitro. J. Gen. Virol. 85:3239-3247.
60. Koppel, B. S., T. P. Poon, A. Khandji, S. G. Pavlakis, and T. A. Pedley. 1996. Subacute sclerosing panencephalitis and acquired immunodeficiency syndrome: role of electroencephalography and magnetic resonance imaging. J. Neuroimaging 6:122-125.
61. Krasinski, K., and W. Borkowsky. 1989. Measles and measles immunity in children infected with human immunodeficiency virus. JAMA 261:2512-2516.
62. Levy, B. M., and R. R. Mirkovic. 1971. An epizootic of measles in a marmoset colony. Lab. Anim. Sci. 21:33-39.
63. Lin, C. Y. 1986. Transient remission after intercurrent measles infection in a patient with hyperimmunoglobulin E syndrome. Pediatr. Res. 20:685-688.
64. Lin, C. Y., M. T. Lin, Y. L. Hsieh, and L. Y. Tsao. 1988. Transient disappearance of immunologic disorders and remission after intercurrent measles infections in children with chronic idiopathic thrombocytopenic purpura. J. Clin. Immunol. 8:207-213.
65. Lorenz, D., and P. Albrecht. 1980. Susceptibility of tamarins (Saguinus) to measles virus. Lab. Anim. Sci. 30:661-665.
66. Lucas, C. J., J. Ubels-Postma, J. M. Galama, and A. Rezee. 1978. Studies on the mechanism of measles virus-induced suppression of lymphocyte functions in vitro: lack of a role for interferon and monocytes. Cell Immunol. 37:448-458.
67. Lucas, S. B., C. S. Peacock, A. Hounnou, K. Brattegaard, K. Koffi, M. Honde, J. Andoh, J. Bell, and K. M. De Cock. 1996. Disease in children infected with HIV in Abidjan, Cote d'Ivoire. BMJ 312:335-338.
68. Markowitz, L. E., F. W. Chandler, E. O. Roldan, M. J. Saldana, K. C. Roach, S. S. Hutchins, S. R. Preblud, C. D. Mitchell, and G. B. Scott. 1988. Fatal measles pneumonia without rash in a child with AIDS. J. Infect. Dis. 158:480-483.
69. Marttila, J., A. Hinkkanen, T. Ziegler, R. Vainionpaa, A. Salmi, and J. Ilonen. 2001. Cell membrane-associated measles virus components inhibit antigen processing. Virology 279:422-428.
70. McChesney, M. B., A. Altman, and M. B. Oldstone. 1988. Suppression of T lymphocyte function by measles virus is due to cell cycle arrest in G1. J. Immunol. 140:1269-1273.
71. McChesney, M. B., R. S. Fujinami, P. W. Lampert, and M. B. Oldstone. 1986. Viruses disrupt functions of human lymphocytes. II. Measles virus suppresses antibody production by acting on B lymphocytes. J. Exp. Med. 163:1331-1336.
72. McChesney, M. B., R. S. Fujinami, N. W. Lerche, P. A. Marx, and M. B. Oldstone. 1989. Virus-induced immunosuppression: infection of peripheral blood mononuclear cells and suppression of immunoglobulin synthesis during natural measles virus infection of rhesus monkeys. J. Infect. Dis. 159:757-760.
73. McChesney, M. B., J. H. Kehrl, A. Valsamakis, A. S. Fauci, and M. B. Oldstone. 1987. Measles virus infection of B lymphocytes permits cellular activation but blocks progression through the cell cycle. J. Virol. 61:3441-3447.
74. McChesney, M. B., and M. B. Oldstone. 1987. Viruses perturb lymphocyte functions: selected principles characterizing virus-induced immunosuppression. Annu. Rev. Immunol. 5:279-304.
75. McConnell, E. M. 1961. Medical memoranda: giant-cell pneumonia. Br. Med. J. ii:288-289.
76. McQuaid, S., S. L. Cosby, K. Koffi, M. Honde, J. Kirk, and S. B. Lucas. 1998. Distribution of measles virus in the central nervous system of HIV-seropositive children. Acta Neuropathol. (Berlin) 96:637-642.
77. Miller, D. L. 1963. Frequency of complications of measles. Brit. Med. J. ii:75-78.
78. Morley, D. 1969. Severe measles in the tropics. Br. Med. J. i:297-300.
79. Moss, W. J., F. Cutts, and D. E. Griffin. 1999. Implications of the human immunodeficiency virus epidemic for control and eradication of measles. Clin. Infect. Dis. 29:106-112.
80. Moss, W. J., M. Monze, J. J. Ryon, T. C. Quinn, D. E. Griffin, and F. Cutts. 2002. Prospective study of measles in hospitalized, human immunodeficiency virus (HIV)-infected and HIV-uninfected children in Zambia. Clin. Infect. Dis. 35:189-196.
81. Mrkic, B., B. Odermatt, M. A. Klein, M. A. Billeter, J. Pavlovic, and R. Cattaneo. 2000. Lymphatic dissemination and comparative pathology of recombinant measles viruses in genetically modified mice. J. Virol. 74:1364-1372.
82. Mrkic, B., J. Pavlovic, T. Rulicke, P. Volpe, C. J. Buchholz, D. Hourcade, J. P. Atkinson, A. Aguzzi, and R. Cattaneo. 1998. Measles virus spread and pathogenesis in genetically modified mice. J. Virol. 72:7420-7427.
83. Muller, C. P., W. Ammerlaan, B. Fleckenstein, S. Krauss, H. Kalbacher, F. Schneider, G. Jung, and K. H. Wiesmuller. 1996. Activation of T cells by the ragged tail of MHC class II-presented peptides of the measles virus fusion protein. Int. Immunol. 8:445-456.
84. Murray, C. J., A. D. Lopez, C. D. Mathers, and C. Stein. 2001. Discussion paper 36. Presented at the Global Programme on Evidence for Health Policy, Geneva, Switzerland.
85. Mustafa, M. M., S. D. Weitman, N. J. Winick, W. J. Bellini, C. F. Timmons, and J. D. Siegel. 1993. Subacute measles encephalitis in the young immunocompromised host: report of two cases diagnosed by polymerase chain reaction and treated with ribavirin and review of the literature. Clin. Infect. Dis. 16:654-660.
86. Nadel, S., K. McGann, R. L. Hodinka, R. Rutstein, and J. Chatten. 1991. Measles giant cell pneumonia in a child with human immunodeficiency virus infection. Pediatr. Infect. Dis. J. 10:542-544.
87. Nanan, R., C. Carstens, and H. W. Kreth. 1995. Demonstration of virus-specific CD8+ memory T cells in measles-seropositive individuals by in vitro peptide stimulation. Clin. Exp. Immunol. 102:40-45.
88. Nanan, R., B. Chittka, M. Hadam, and H. W. Kreth. 1999. Measles virus infection causes transient depletion of activated T cells from peripheral circulation. J. Clin. Virol. 12:201-210.
89. 0-like block leads to suppression of retinoblastoma protein expression. J. Virol. 73:1894-1901.
90. Niewiesk, S., I. Eisenhuth, A. Fooks, J. C. Clegg, J. J. Schnorr, S. Schneider-Schaulies, and V. ter Meulen. 1997. Measles virus-induced immune suppression in the cotton rat (Sigmodon hispidus) model depends on viral glycoproteins. J. Virol. 71:7214-7219.
91. Niewiesk, S., I. Eisenhuth, and V. ten Meulen. 1997. Protective immunity, but suppressed immune responses to third party antigens are generated in cotton rats during measles virus infection. Biochem. Soc. Trans. 25:355S.
92. Niewiesk, S., J. Schneider-Schaulies, H. Ohnimus, C. Jassoy, S. Schneider-Schaulies, L. Diamond, J. S. Logan, and V. ter Meulen. 1997. CD46 expression does not overcome the intracellular block of measles virus replication in transgenic rats. J. Virol. 71:7969-7973.
93. Okamura, A., O. Itakura, M. Yoshioka, M. Kubota, H. Kikuta, and K. Kobayashi. 2001. Unusual presentation of measles giant cell pneumonia in a patient with acquired immunodeficiency syndrome. Clin. Infect. Dis. 32:E57-E58.
94. Oldstone, M. B., H. Lewicki, D. Thomas, A. Tishon, S. Dales, J. Patterson, M. Manchester, D. Homann, D. Naniche, and A. Holz. 1999. Measles virus infection in a transgenic model: virus-induced immunosuppression and central nervous system disease. Cell 98:629-640.
95. Oshitani, H., H. Suzuki, M. E. Mpabalwani, K. Mizuta, and Y. Numazaki. 1996. Measles case fatality by sex, vaccination status, and HIV-1 antibody in Zambian children. Lancet 348:415.
96. Osunkoya, B. O., G. I. Adeleye, T. A. Adejumo, and L. S. Salimonu. 1974. Studies on leukocyte cultures in measles. II. Detection of measles virus antigen in human leucocytes by immunofluorescence. Arch. Gesamte Virusforsch. 44:323-329.
97. Palumbo, P., L. Hoyt, K. Demasio, J. Oleske, and E. Connor. 1992. Population-based study of measles and measles immunization in human immunodeficiency virus-infected children. Pediatr. Infect. Dis. J. 11:1008-1014.
98. Panum, P. L. 1939. Observations made during the epidemic of measles on Faroe Islands in the year 1846. Med. Class 3:829-886.
99. Peebles, T. C., K. McCarthy, J. F. Enders, and A. Holloway. 1957. Behavior of monkeys after inoculation of virus derived from patients with measles and propagated in tissue culture together with observations on spontaneous infections of these animals by an agent exhibiting similar antigenic properties. J. Immunol. 78:63-74.
100. Permar, S. R., S. A. Klumpp, K. G. Mansfield, A. A. Carville, D. A. Gorgone, M. A. Lifton, J. E. Schmitz, K. A. Reimann, F. P. Polack, D. E. Griffin, and N. L. Letvin. 2004. Limited contribution of humoral immunity to the clearance of measles viremia in rhesus monkeys. J. Infect. Dis. 190:998-1005.
101. + lymphocytes in control and clearance of measles virus infection of rhesus monkeys. J. Virol. 77:4396-4400.
102. Permar, S. R., W. J. Moss, J. J. Ryon, D. C. Douek, M. Monze, and D. E. Griffin. 2003. Increased thymic output during acute measles virus infection. J. Virol. 77:7872-7879.
103. Permar, S. R., W. J. Moss, J. J. Ryon, M. Monze, F. Cutts, T. C. Quinn, and D. E. Griffin. 2001. Prolonged measles virus shedding in human immunodeficiency virus-infected children, detected by reverse transcriptase-polymerase chain reaction. J. Infect. Dis. 183:532-538.
104. Pette, M., U. G. Liebert, U. Gobel, H. Grosse-Wilde, H. P. Hartung, and K. V. Toyka. 1993. Measles virus-directed responses of CD4+ T lymphocytes in MS patients and healthy individuals. Neurology 43:2019-2025.
105. Potkay, S., J. R. Ganaway, N. G. Rogers, and R. Kinard. 1966. An epizootic of measles in a colony of rhesus monkeys (Macaca mulatta). Am. J. Vet. Res. 27:331-334.
106. Remfry, J. 1976. A measles epizootic with 5 deaths in newly-imported rhesus monkeys (Macaca mulatta). Lab. Anim. 10:49-57.
107. Rose, J. W., W. J. Bellini, D. E. McFarlin, and H. F. McFarland. 1984. Human cellular immune response to measles virus polypeptides. J. Virol. 49:988-991.
108. Ross, L. A., K. S. Kim, W. H. Mason, Jr., and E. Gomperts. 1990. Successful treatment of disseminated measles in a patient with acquired immunodeficiency syndrome: consideration of antiviral and passive immunotherapy. Am. J. Med. 88:313-314.
109. Rudy, B. J., R. M. Rutstein, and J. Pinto-Martin. 1994. Responses to measles immunization in children infected with human immunodeficiency virus. J. Pediatr. 125:72-74.
110. Ryon, J. J., W. J. Moss, M. Monze, and D. E. Griffin. 2002. Functional and phenotypic changes in circulating lymphocytes from hospitalized Zambian children with measles. Clin. Diagn. Lab. Immunol. 9:994-1003.
111. Salonen, R., J. Ilonen, and A. Salmi. 1988. Measles virus infection of unstimulated blood mononuclear cells in vitro: antigen expression and virus production preferentially in monocytes. Clin. Exp. Immunol. 71:224-228.
112. Salonen, R., J. Ilonen, and A. A. Salmi. 1989. Measles virus inhibits lymphocyte proliferation in vitro by two different mechanisms. Clin. Exp. Immunol. 75:376-380.
113. Samsi, T. K., T. Ruspandji, I. Susanto, and K. Gunawan. 1992. Risk factors for severe measles. Southeast Asian J. Trop. Med. Public Health 23:497-503.
114. Sanchez-Lanier, M., P. Guerin, L. C. McLaren, and A. D. Bankhurst. 1988. Measles virus-induced suppression of lymphocyte proliferation. Cell Immunol. 116:367-381.
115. Schlender, J., J. J. Schnorr, P. Spielhoffer, T. Cathomen, R. Cattaneo, M. A. Billeter, V. ter Meulen, and S. Schneider-Schaulies. 1996. Interaction of measles virus glycoproteins with the surface of uninfected peripheral blood lymphocytes induces immunosuppression in vitro. Proc. Natl. Acad. Sci. USA 93:13194-13199.
116. Schneider-Schaulies, S., H. W. Kreth, G. Hofmann, M. Billeter, and V. Ter Meulen. 1991. Expression of measles virus RNA in peripheral blood mononuclear cells of patients with measles, SSPE, and autoimmune diseases. Virology 182:703-711.
117. Schneider-Schaulies, S., U. G. Liebert, Y. Segev, B. Rager-Zisman, M. Wolfson, and V. ter Meulen. 1992. Antibody-dependent transcriptional regulation of measles virus in persistently infected neural cells. J. Virol. 66:5534-5541.
118. Sension, M. G., T. C. Quinn, L. E. Markowitz, M. J. Linnan, T. S. Jones, H. L. Francis, N. Nzilambi, M. N. Duma, and R. W. Ryder. 1988. Measles in hospitalized African children with human immunodeficiency virus. Am. J. Dis. Child. 142:1271-1272.
119. Shingai, M., N. Inoue, T. Okuno, M. Oka be, T. Akazawa, Y. Miyamoto, M. Ayata, K. Honda, M. Kurita-Taniguchi, M. Matsumoto, H. Ogura, T. Taniguchi, and T. Seya. 2005. Wild-type measles virus infection in human CD46/CD150-transgenic mice: CD11c-positive dendritic cells establish systemic viral infection. J. Immunol. 175:3252-3261.
120. Sullivan, J. L., D. W. Barry, P. Albrecht, and S. J. Lucas. 1975. Inhibition of lymphocyte stimulation by measles virus. J. Immunol. 114:1458-1461.
121. Sullivan, J. L., D. W. Barry, S. J. Lucas, and P. Albrecht. 1975. Measles infection of human mononuclear cells. I. Acute infection of peripheral blood lymphocytes and monocytes. J. Exp. Med. 142:773-784.
122. Valsamakis, A., H. Kaneshima, and D. E. Griffin. 2001. Strains of measles vaccine differ in their ability to replicate in and damage human thymus. J. Infect. Dis. 183:498-502.
123. van Binnendijk, R. S., M. C. Poelen, K. C. Kuijpers, A. D. Osterhaus, and F. G. Uytdehaag. 1990. The predominance of CD8+ T cells after infection with measles virus suggests a role for CD8+ class 1 MHC-restricted cytotoxic T lymphocytes (CTL) in recovery from measles. Clonal analyses of human CD8+ class I MHC-restricted CTL. J. Immunol. 144:2394-2399.
124. van Binnendijk, R. S., M. C. Poelen, G. van Amerongen, P. de Vries, and A. D. Osterhaus. 1997. Protective immunity in macaques vaccinated with live attenuated, recombinant, and subunit measles vaccines in the presence of passively acquired antibodies. J. Infect. Dis. 175:524-532.
125. van Binnendijk, R. S., R. W. van der Heijden, G. van Amerongen, F. G. UytdeHaag, and A. D. Osterhaus. 1994. Viral replication and development of specific immunity in macaques after infection with different measles virus strains. J. Infect. Dis. 170:443-448.
126. van Binnendijk, R. S., J. P. Versteeg-van Oosten, M. C. Poelen, H. F. Brugghe, P. Hoogerhout, A. D. Osterhaus, and F. G. Uytdehaag. 1993. Human HLA class I- and HLA class II-restricted cloned cytotoxic T lymphocytes identify a cluster of epitopes on the measles virus fusion protein. J. Virol. 67:2276-2284.
127. Vigliano, P., P. Boffi, M. T. Giordana, P. A. Tovo, E. Palomba, and R. Rigardetto. 1995. Subacute measles encephalitis in a boy with perinatal HIV-1 infection. Dev. Med. Child Neurol. 37:1117-1119.
128. Vuorinen, T., P. Peri, and R. Vainionpaa. 2003. Measles virus induces apoptosis in uninfected bystander T cells and leads to granzyme B and caspase activation in peripheral blood mononuclear cell cultures. Eur. J. Clin. Investig. 33:434-442.
129. Ward, B. J., and D. E. Griffin. 1993. Changes in cytokine production after measles virus vaccination: predominant production of IL-4 suggests induction of a Th2 response. Clin. Immunol. Immunopathol. 67:171-177.
130. Ward, B. J., R. T. Johnson, A. Vaisberg, E. Jauregui, and D. E. Griffin. 1991. Cytokine production in vitro and the lymphoproliferative defect of natural measles virus infection. Clin. Immunol. Immunopathol. 61:236-248.
131. Ward, B. J., R. T. Johnson, A. Vaisberg, E. Jauregui, and D. E. Griffin. 1990. Spontaneous proliferation of peripheral mononuclear cells in natural measles virus infection: identification of dividing cells and correlation with mitogen responsiveness. Clin. Immunol. Immunopathol. 55:315-326.
132. Welstead, G. G., C. Iorio, R. Draker, J. Bayani, J. Squire, S. Vongpunsawad, R. Cattaneo, and C. D. Richardson. 2005. Measles virus replication in lymphatic cells and organs of CD150 (SLAM) transgenic mice. Proc. Natl. Acad. Sci. USA 102:16415-16420.
133. Wesley, A., H. M. Coovadia, and L. Henderson. 1978. Immunological recovery after measles. Clin. Exp. Immunol. 32:540-544.
134. Wesley, A. G., H. M. Coovadia, and P. Kiepiela. 1982. Further predictive indices of clinical severity of measles. S. Afr. Med. J. 61:663-665.
135. Whittle, H. C., J. Dossetor, A. Oduloju, A. D. Bryceson, and B. M. Greenwood. 1978. Cell-mediated immunity during natural measles infection. J. Clin. Investig. 62:678-684.
136. Wu, V. H., H. McFarland, K. Mayo, L. Hanger, D. E. Griffin, and S. Dhib-Jalbut. 1993. Measles virus-specific cellular immunity in patients with vaccine failure. J. Clin. Microbiol. 31:118-122.
137. Yanagi, Y., B. A. Cubitt, and M. B. Oldstone. 1992. Measles virus inhibits mitogen-induced T cell proliferation but does not directly perturb the T cell activation process inside the cell. Virology 187:280-289.
138. Yoshioka, K., H. Miyata, and S. Maki. 1981. Transient remission of juvenile rheumatoid arthritis after measles. Acta Paediatr. Scand. 70:419-420.
139. Zhu, Y. D., J. Heath, J. Collins, T. Greene, L. Antipa, P. Rota, W. Bellini, and M. McChesney. 1997. Experimental measles. II. Infection and immunity in the rhesus macaque. Virology 233:85-92.
140. Zweiman, B. 1971. In vitro effects of measles virus on proliferating human lymphocytes. J. Immunol. 106:1154-1158.